Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAM-01: Low Dose Tamoxifen in Breast Intraepithelial Neoplasia
NCT01357772Phase 3Active, not recruiting
- Start
- Nov 2008
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tamoxifen in Breast Intraepithelial Neoplasia. Started Nov 2008; status: active, not recruiting.
02
Drugs
tamoxifen
03
Conditions
Breast Intraepithelial Neoplasia
Beyond the preview
Go deeper on NCT01357772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01357772.